Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

300357.SZ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$11.36B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.26.51.15%15%10.8-
$16.48

Current Fair Value

24% downside

Overvalued by 24% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$11.36 Billion
Enterprise Value$10.59 Billion
Annual dividend$0.25
Dividend yield1.15%
Earnings per Share$0.73
Beta0.37
Outstanding Shares523,583,999

Return

Return on Equity14.57%ROE
Return on Assets13.28%
Return on Invested Capital15.69%

Valuation & Multiples

P/E Ratio26.49P/E Ratio
PEG445.55PEG
Price to Sales10.85Price to Sales
Price to Book Ratio4.34Price to Book Ratio
Enterprise Value to Revenue9.47
Enterprise Value to EBIT22.11
Enterprise Value to Net Income24
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 26, 2026
EPS
$0.34
Est. $0.16
Revenue
$395.83 M
Est. $266.02 M

Next Earnings Call

Expected Date
April 16, 2027
EPS Estimate
$0.16
Consensus analyst estimate
Revenue Estimate
$410.17 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

1,808 employees
CEO: Mushuang Hu

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical enterprise, primarily engaged in the discovery, development, production, and sale of medicinal products. The company's core focus is on pharmaceuticals designed ...